Cargando…

Correspondence on “Re‐examining remission definitions in rheumatoid arthritis: considering the 28‐Joint Disease Activity Score, C‐reactive protein level and patient global assessment” by Felson et al

Detalles Bibliográficos
Autores principales: Ferreira, Ricardo J. O., Welsing, Paco M. J., Jacobs, Johannes W. G., Gossec, Laure, Ndosi, Mwidimi, Machado, Pedro M., van der Heijde, Désirée, da Silva, José A. P.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wiley Periodicals, Inc. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8916548/
https://www.ncbi.nlm.nih.gov/pubmed/35089652
http://dx.doi.org/10.1002/acr2.11402
_version_ 1784668326684786688
author Ferreira, Ricardo J. O.
Welsing, Paco M. J.
Jacobs, Johannes W. G.
Gossec, Laure
Ndosi, Mwidimi
Machado, Pedro M.
van der Heijde, Désirée
da Silva, José A. P.
author_facet Ferreira, Ricardo J. O.
Welsing, Paco M. J.
Jacobs, Johannes W. G.
Gossec, Laure
Ndosi, Mwidimi
Machado, Pedro M.
van der Heijde, Désirée
da Silva, José A. P.
author_sort Ferreira, Ricardo J. O.
collection PubMed
description
format Online
Article
Text
id pubmed-8916548
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Wiley Periodicals, Inc.
record_format MEDLINE/PubMed
spelling pubmed-89165482022-03-18 Correspondence on “Re‐examining remission definitions in rheumatoid arthritis: considering the 28‐Joint Disease Activity Score, C‐reactive protein level and patient global assessment” by Felson et al Ferreira, Ricardo J. O. Welsing, Paco M. J. Jacobs, Johannes W. G. Gossec, Laure Ndosi, Mwidimi Machado, Pedro M. van der Heijde, Désirée da Silva, José A. P. ACR Open Rheumatol Letter to the Editor Wiley Periodicals, Inc. 2022-01-28 /pmc/articles/PMC8916548/ /pubmed/35089652 http://dx.doi.org/10.1002/acr2.11402 Text en © 2022 The Authors. ACR Open Rheumatology published by Wiley Periodicals LLC on behalf of American College of Rheumatology. https://creativecommons.org/licenses/by-nc/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc/4.0/ (https://creativecommons.org/licenses/by-nc/4.0/) License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited and is not used for commercial purposes.
spellingShingle Letter to the Editor
Ferreira, Ricardo J. O.
Welsing, Paco M. J.
Jacobs, Johannes W. G.
Gossec, Laure
Ndosi, Mwidimi
Machado, Pedro M.
van der Heijde, Désirée
da Silva, José A. P.
Correspondence on “Re‐examining remission definitions in rheumatoid arthritis: considering the 28‐Joint Disease Activity Score, C‐reactive protein level and patient global assessment” by Felson et al
title Correspondence on “Re‐examining remission definitions in rheumatoid arthritis: considering the 28‐Joint Disease Activity Score, C‐reactive protein level and patient global assessment” by Felson et al
title_full Correspondence on “Re‐examining remission definitions in rheumatoid arthritis: considering the 28‐Joint Disease Activity Score, C‐reactive protein level and patient global assessment” by Felson et al
title_fullStr Correspondence on “Re‐examining remission definitions in rheumatoid arthritis: considering the 28‐Joint Disease Activity Score, C‐reactive protein level and patient global assessment” by Felson et al
title_full_unstemmed Correspondence on “Re‐examining remission definitions in rheumatoid arthritis: considering the 28‐Joint Disease Activity Score, C‐reactive protein level and patient global assessment” by Felson et al
title_short Correspondence on “Re‐examining remission definitions in rheumatoid arthritis: considering the 28‐Joint Disease Activity Score, C‐reactive protein level and patient global assessment” by Felson et al
title_sort correspondence on “re‐examining remission definitions in rheumatoid arthritis: considering the 28‐joint disease activity score, c‐reactive protein level and patient global assessment” by felson et al
topic Letter to the Editor
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8916548/
https://www.ncbi.nlm.nih.gov/pubmed/35089652
http://dx.doi.org/10.1002/acr2.11402
work_keys_str_mv AT ferreiraricardojo correspondenceonreexaminingremissiondefinitionsinrheumatoidarthritisconsideringthe28jointdiseaseactivityscorecreactiveproteinlevelandpatientglobalassessmentbyfelsonetal
AT welsingpacomj correspondenceonreexaminingremissiondefinitionsinrheumatoidarthritisconsideringthe28jointdiseaseactivityscorecreactiveproteinlevelandpatientglobalassessmentbyfelsonetal
AT jacobsjohanneswg correspondenceonreexaminingremissiondefinitionsinrheumatoidarthritisconsideringthe28jointdiseaseactivityscorecreactiveproteinlevelandpatientglobalassessmentbyfelsonetal
AT gosseclaure correspondenceonreexaminingremissiondefinitionsinrheumatoidarthritisconsideringthe28jointdiseaseactivityscorecreactiveproteinlevelandpatientglobalassessmentbyfelsonetal
AT ndosimwidimi correspondenceonreexaminingremissiondefinitionsinrheumatoidarthritisconsideringthe28jointdiseaseactivityscorecreactiveproteinlevelandpatientglobalassessmentbyfelsonetal
AT machadopedrom correspondenceonreexaminingremissiondefinitionsinrheumatoidarthritisconsideringthe28jointdiseaseactivityscorecreactiveproteinlevelandpatientglobalassessmentbyfelsonetal
AT vanderheijdedesiree correspondenceonreexaminingremissiondefinitionsinrheumatoidarthritisconsideringthe28jointdiseaseactivityscorecreactiveproteinlevelandpatientglobalassessmentbyfelsonetal
AT dasilvajoseap correspondenceonreexaminingremissiondefinitionsinrheumatoidarthritisconsideringthe28jointdiseaseactivityscorecreactiveproteinlevelandpatientglobalassessmentbyfelsonetal